leaving-tax
Pfizer-Allergan deal refocuses market on U.S. tax-inversion rules
November 15, 2015 by creative · Leave a Comment
Pfizer Inc's buyout bid for Allergan Plc has financial markets on edge over a possible new move by the U.S. Treasury Department against tax-inversion deals, but the outlook for any such
Here is the original post:
Pfizer-Allergan deal refocuses market on U.S. tax-inversion rules